Learning and memory deficits associated with autoimmunity: Significance in aging and Alzheimer's disease

Michael J. Forster, Konrad C. Retz, Harbans Lal

Research output: Contribution to journalArticle

30 Citations (Scopus)

Abstract

This review focuses on the significance of brain‐reactive antibodies (BRA) to ageassociated cognitive decline and Alzheimerapos;s disease, drawing on evidence available from both human and animal studies. Human studies suggest a relationship between BRA formation, age, and Alzheimerapos;s disease. Experiments with mice indicate that BRA formation and age‐related learning deficits are accelerated following adoptive transfer of immunity from aged to young mice. Furthermore, mice selected for autoimmunity and early formation of BRA also show accelerated, age‐related learning deficits. It is concluded that a further analysis of the nature of BRA and their targets within the nervous system could reveal important immunological influences in cognitive dysfunctions related to aging and Alzheimerapos;s disease. It is suggested that treatments that delay or prevent age‐related immunological dysfunctions be evaluated for their ability to retard age‐associated cognitive decline.

Original languageEnglish
Pages (from-to)253-273
Number of pages21
JournalDrug Development Research
Volume15
Issue number2-3
DOIs
StatePublished - 1 Jan 1988

Fingerprint

Memory Disorders
Autoimmunity
Antibody Formation
Alzheimer Disease
Learning
Aptitude
Adoptive Transfer
Antibodies
Adaptive Immunity
Nervous System
Cognitive Dysfunction
Therapeutics

Keywords

  • BXSB/MpJ
  • C57BL/6NNia
  • MRL/MpJ– +
  • MRL/MpJ–lpr
  • NZB/BINJ
  • NZBWFJ
  • brain‐reactive antibodies
  • dementia
  • immune system
  • one‐way active avoidance learning
  • pharmacotherapy
  • senescence

Cite this

@article{01279f76eebf43bfac07c57d45badc74,
title = "Learning and memory deficits associated with autoimmunity: Significance in aging and Alzheimer's disease",
abstract = "This review focuses on the significance of brain‐reactive antibodies (BRA) to ageassociated cognitive decline and Alzheimerapos;s disease, drawing on evidence available from both human and animal studies. Human studies suggest a relationship between BRA formation, age, and Alzheimerapos;s disease. Experiments with mice indicate that BRA formation and age‐related learning deficits are accelerated following adoptive transfer of immunity from aged to young mice. Furthermore, mice selected for autoimmunity and early formation of BRA also show accelerated, age‐related learning deficits. It is concluded that a further analysis of the nature of BRA and their targets within the nervous system could reveal important immunological influences in cognitive dysfunctions related to aging and Alzheimerapos;s disease. It is suggested that treatments that delay or prevent age‐related immunological dysfunctions be evaluated for their ability to retard age‐associated cognitive decline.",
keywords = "BXSB/MpJ, C57BL/6NNia, MRL/MpJ– +, MRL/MpJ–lpr, NZB/BINJ, NZBWFJ, brain‐reactive antibodies, dementia, immune system, one‐way active avoidance learning, pharmacotherapy, senescence",
author = "Forster, {Michael J.} and Retz, {Konrad C.} and Harbans Lal",
year = "1988",
month = "1",
day = "1",
doi = "10.1002/ddr.430150216",
language = "English",
volume = "15",
pages = "253--273",
journal = "Drug Development Research",
issn = "0272-4391",
publisher = "John Wiley and Sons Inc.",
number = "2-3",

}

Learning and memory deficits associated with autoimmunity : Significance in aging and Alzheimer's disease. / Forster, Michael J.; Retz, Konrad C.; Lal, Harbans.

In: Drug Development Research, Vol. 15, No. 2-3, 01.01.1988, p. 253-273.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Learning and memory deficits associated with autoimmunity

T2 - Significance in aging and Alzheimer's disease

AU - Forster, Michael J.

AU - Retz, Konrad C.

AU - Lal, Harbans

PY - 1988/1/1

Y1 - 1988/1/1

N2 - This review focuses on the significance of brain‐reactive antibodies (BRA) to ageassociated cognitive decline and Alzheimerapos;s disease, drawing on evidence available from both human and animal studies. Human studies suggest a relationship between BRA formation, age, and Alzheimerapos;s disease. Experiments with mice indicate that BRA formation and age‐related learning deficits are accelerated following adoptive transfer of immunity from aged to young mice. Furthermore, mice selected for autoimmunity and early formation of BRA also show accelerated, age‐related learning deficits. It is concluded that a further analysis of the nature of BRA and their targets within the nervous system could reveal important immunological influences in cognitive dysfunctions related to aging and Alzheimerapos;s disease. It is suggested that treatments that delay or prevent age‐related immunological dysfunctions be evaluated for their ability to retard age‐associated cognitive decline.

AB - This review focuses on the significance of brain‐reactive antibodies (BRA) to ageassociated cognitive decline and Alzheimerapos;s disease, drawing on evidence available from both human and animal studies. Human studies suggest a relationship between BRA formation, age, and Alzheimerapos;s disease. Experiments with mice indicate that BRA formation and age‐related learning deficits are accelerated following adoptive transfer of immunity from aged to young mice. Furthermore, mice selected for autoimmunity and early formation of BRA also show accelerated, age‐related learning deficits. It is concluded that a further analysis of the nature of BRA and their targets within the nervous system could reveal important immunological influences in cognitive dysfunctions related to aging and Alzheimerapos;s disease. It is suggested that treatments that delay or prevent age‐related immunological dysfunctions be evaluated for their ability to retard age‐associated cognitive decline.

KW - BXSB/MpJ

KW - C57BL/6NNia

KW - MRL/MpJ– +

KW - MRL/MpJ–lpr

KW - NZB/BINJ

KW - NZBWFJ

KW - brain‐reactive antibodies

KW - dementia

KW - immune system

KW - one‐way active avoidance learning

KW - pharmacotherapy

KW - senescence

UR - http://www.scopus.com/inward/record.url?scp=0024147042&partnerID=8YFLogxK

U2 - 10.1002/ddr.430150216

DO - 10.1002/ddr.430150216

M3 - Article

AN - SCOPUS:0024147042

VL - 15

SP - 253

EP - 273

JO - Drug Development Research

JF - Drug Development Research

SN - 0272-4391

IS - 2-3

ER -